baber/WOPTO huggingface dataset:
Patent FI-912146-A0 (FI)
Inventor: DAPONTE DIEGO H
IPC: D04H1/54
Filed: 1991-05-03
Abstract: Three-dimensional nonwoven webs comprise at least one layer consisting of drawn and unoriented thermoplatic fibers formed from a blend of polypropylene and polybutylene, wherein the blend by weight is from 90% to 70% polypropylene and from 10% to 30% polybutylene. The blend can be a blend of a homopolymer of polypropylene and a homopolymer of polybutylene: a homopolymer of polypropylene and a copolymer of polybutlene: a copolymer of polypropylene and a homopolymer of polybutylene: and a copolymer of polypropylene and a copolymer of polybutylene. In addition, ternary blends comprising polypropylene, polybutylene and a terpolymer (propylene, ethylene, and l-butene) are disclosed. The resulting nonwoven webs have high strength, toughness, and tear resistance.
Patent FI-913822-A0 (FI)
Inventor: DEMAREZ PHILIPPE
IPC: B22D11/00
Filed: 1991-08-12
Abstract: According to this method, the metal is solidified in a continuous-casting ingot mould consisting of two cooled rolls (2) rotating in opposite directions and arranged opposite each other so as to define a casting space between them, a solidified steel strip (3) is extracted continuously from the ingot mould, and, under the ingot mould, the said strip is subjected to a quenching medium (6) in order to cool it sufficiently rapidly in order to prevent the formation of austenite. This medium may consist of a quenching bath, placed in a container (4) arranged under the rolls (2), and whose bottom is pierced with an opening (5) for the passage of the solidified strip (3). It may also consist of an inert gas in the liquid state sprayed onto the product by nozzles. The steel strips obtained are easier to trim and to coil on exit from the casting line, by virtue of the absence of martensite in the ferritic matrix. 
<IMAGE>
Patent FI-915491-A0 (FI)
Inventor: HERBRANSON DALE E
IPC: A61K47/16
Filed: 1991-11-21
Abstract: Described is a stable pharmaceutical composition of 3-(hydroxymethyl-5,5-diphenylhydantoin disodium phosphate ester, the prodrug of 5,5-diphenylhydantoin (phenytoin) a commonly used drug for the treatment and management of epilepsy and other types of convulsive states. It has been found that degradation of the prodrug to phenytoin can be controlled by controlling the pH of the composition. Controlling the pH to between 8.3 to 9.4 results in the production of diphenylglycinamide as the primary degradant and minimization of degradation to phenytoin. If the pH is maintained at a lower or higher value, then the degradation pattern changes, with earlier than expected product failure.
Patent FI-924916-A0 (FI)
Inventor: SCHINDLER ANTON
IPC: A61K47/34
Filed: 1992-10-29
Abstract: Random copolymers of caprolactone containing 5-25 mole-% trimethylene carbonate are shaped into tubular devices to form cylindrical capsules to be used for the sustained delivery of drugs after subcutaneous implantation in humans or animals.
Patent FI-925069-A0 (FI)
Inventor: CHENARD BERTRAND LEO
IPC: A61P25/28
Filed: 1992-11-09
Abstract: PCT No. PCT/US91/01470 Sec. 371 Date Nov. 6, 1992 Sec. 102(e) Date Nov. 6, 1992 PCT Filed Mar. 4, 1991 PCT Pub. No. WO91/17156 PCT Pub. Date Nov. 14, 1991.5-(1-Hydroxy-2-piperidinopropyl)-2(1H,3H)-indolone derivatives and analogs; pharmaceutical compositions thereof; methods of treating CNS disorders therewith; and intermediates useful in the preparation of said compounds.
Patent FI-933479-A0 (FI)
Inventor: VERNONDIER DAVID RICHARD
IPC: F21V23/00
Filed: 1993-08-05
Abstract: A lighting system includes a plurality of modular components, comprising elongate strips (65) of different finite lengths having elongate lighting circuits (67-69) therein and connector means (110) for connecting adjacent strips (65) end to end and electrically conecting the lighting circuits (67-69) thereon to enable a voltage to be applied across a series of illuminating devices (60, 60') provided at predetermined spaced locations along the length of the strips (65) so connected. The illuminating devices on each strip are connected in series and the series connected illuminating devices associated with each strip are connected in parallel with the series connected illuminating devices associated with each of the other strips. The series connections of the illuminating devices associated with the respective strips are balanced so that they are voltage compatible with one another. In some embodiments a plurality of series connected illuminating devices are provided on each strip. Ring voltage supply lines (200, 201) and voltage pulse control (202) lines may also be provided on the strips (65).
Patent FI-934298-A0 (FI)
Inventor: PETERSEN HENNING
IPC: A61K31/4433
Filed: 1993-09-30
Abstract: The invention provides crystalline Tiagabine hydrochloride monohydrate, process for its preparation, compositions containing the same and its therapeutic use as anti-epileptic agent.
Patent FI-934848-A0 (FI)
Inventor: TUOMINEN ARI
IPC: B29C33/48
Filed: 1993-11-02
Abstract: The present invention relates to a method and a mould for forming an expansion, such as a socket, in a plastic pipe, and a plastic pipe. According to the method, the heated end of the pipe is placed in an external mould (2) and pressed against the mould surface (6) to form a socket. Two grooves (8, 9) can be formed in the socket by a simple method, using a mould ring (12) which is separate from the other parts (3, 4) of the mould and by means of which the grooves of the socket are formed. The ring is simultaneously locked into the socket (7), thereby functioning as a reinforcement ring. <IMAGE>
Patent FI-942274-A0 (FI)
Inventor: LESMANN JOERG
IPC: C10N30/16
Filed: 1994-05-16
Abstract: PCT No. PCT/EP92/02248 Sec. 371 Date May 19, 1994 Sec. 102(e) Date May 19, 1994 PCT Filed Sep. 29, 1992 PCT Pub. No. WO93/09670 PCT Pub. Date May 27, 19931,3,5-Triazine-2,4,6-tris-alkylaminocarboxylic acid derivatives of the general formula (I): 1,3,5-triazine-2,4,6-tris[NH-(CH2)n-CO-O-R1] are employed as biocidal or biostatic agents in aqueous systems, in particular in cooling lubricants. Fungicides, for example pyrithione or derivatives thereof and/or N-alkyl-diazenium dioxide salts, can be added to the aqueous systems. 0.05 to 0.40% by weight of the 1,3,5-triazine-2,4,6-alkylaminocarboxylic acid derivatives and 0.0001 to 0.2% by weight of fungicides are sufficient to maintain the biocidal or biostatic actions.
Patent FI-951356-A0 (FI)
Inventor: ZUCKERMANN RONALD N
IPC: A61K48/00
Filed: 1995-03-22
Abstract: Poly N-substituted Glycines (poly NSGs), wherein the substituents bear purine or pyrimidine bases (R<9>) every second glycine: <CHEM> In addition, a solid phase method for the synthesis of N-substituted oligomers of more general structures is disclosed.The poly NSGs obtainable by this method can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two "sub-monomers" directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound  alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using the automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.
Patent FI-952530-A0 (FI)
Inventor: KESKITALO ILKKA
IPC: H04B1/7115
Filed: 1995-05-24
Abstract: PCT No. PCT/FI96/00287 Sec. 371 Date Nov. 14, 1997 Sec. 102(e) Date Nov. 14, 1997 PCT Filed May 23, 1996 PCT Pub. No. WO96/37973 PCT Pub. Date Nov. 28, 1996A method for steering an antenna beam and base station equipment including at least one antenna array having a plurality of elements and at least one channel unit having a means for phasing a signal to be transmitted and received by the antenna array such that gain from the antenna array is the greatest in the desired direction. In order to improve the spectral efficiency of the system, the channel unit includes a means for searching for the incoming directions and delays of the received signal components and a means for controlling the phasing means of the opposite transmission direction based on the information.
Patent FI-973087-A0 (FI)
Inventor: ADAMS STEVEN P
IPC: A61K31/00
Filed: 1997-07-22
Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.
Patent FI-973586-A0 (FI)
Inventor: HEMM DIETER
IPC: C11D7/06
Filed: 1997-09-02
Abstract: PCT No. PCT/EP96/00792 Sec. 371 Date Oct. 6, 1997 Sec. 102(e) Date Oct. 6, 1997 PCT Filed Feb. 27, 1996 PCT Pub. No. WO96/27653 PCT Pub. Date Sep. 12, 1996Transport- and storage-stable paste-form detergents based on sodium hydroxide that are easily processed and handled are obtained by thickening concentrated aqueous sodium hydroxide preparations with glycols, glycol derivatives, alkanolamines, or alkanolamine derivatives. The detergents also can contain builders and other typical detergent composition ingredients.
Patent FI-973665-A0 (FI)
Inventor: COMBS JEROME T
IPC: G01H15/00
Filed: 1997-09-12
Abstract: A device or a process for analysis of acoustic reflectance of components of an ear involves directing, into the ear canal, acoustic waves covering a range of frequencies including resonance frequencies of ear components such as the tympanic membrane. Measurements are made without pressurizing the ear canal and contact between the device and the ear does not need to be air-tight. Accordingly, the patient experiences essentially no discomfort from use of the device. The device detects and combines the incident and reflected waves to produce what is called an acoustic reflectance curve. The shape of a region of the acoustic reflectance curve is electronically measured in order to obtain an indicator of ear condition which is substantially independent of a line of sight between a sound source and the tympanic membrane. This indicator is based on a mesurement of the resonance characteristic, or freedom of motion, of the tympanic membrane or other ear component being analyzed. One such measurement is the rate of change of the acoustic reflectance with respect to frequency. Since resonance typically causes a null to appear in the acoustic reflectance curve, this measurement of the rate of change is particularly informative if measured around the null. The rate of change measured around the null may be presented as an angle measurement, a gradient or slope measurement, a width measurement, or other form of measurement of the shape of the null. In one embodiment, the steepest slopes on either side of a null are used to define an angle, herein called a spectral gradient. Diagnosis of an ear pathology, such as abnormal pressure or presence of fluid in the middle ear or such as conductive hearing loss, may be based on this measure alone. Because of the rate of change of an acoustic reflectance measurement is relatively constant for a given ear, regardless of the quality of the line of sight to the tympanic membrane, the effect, if any, of user training on such measurements is significantly reduced. Accordingly, the process and device of the invention are useful in many kinds of diagnostic situations with respect to ear pathology, but particularly in those involving screening of the ears of young children for common pathologies such as otitis media, even by untrained personnel.
Patent IL-88755-A0 (IL)
Title: Purinyl and pyrimidinyl cyclobutane derivatives and pharmaceutical and veterinary compositions containing the same
IPC: C07D473/32
Filed: 1988-12-21
Abstract: Antiviral activity is exhibited by compounds having the formula <CHEM> and pharmaceutically acceptable salts thereof wherein R2 and R3 are independently hydrogen, -PO3H2 or   - @-X7 and R1 is either a purine, pyrimidine or an analog thereof. <
Patent FI-20000397-A0 (FI)
Inventor: VAEHAELAE MARTTI
IPC: B29C48/15
Filed: 2000-02-21
Abstract: This invention concerns a process for coating a substrate, and an extrusion coating structure. According to the present process, the coating is provided by producing a bimodal polyethylene composition by subjecting ethylene, optionally with hydrogen and/or comonomers to polymerization or copolymerization reactions in a multistage polymerization sequence of successive polymerization stages. The polymerization reactions are carried out in the presence of a single site catalyst capable of forming a composition which comprises a low molecular weight component with an MFR<SUB>2 </SUB>of 20 g/10 min or more and a density higher than the density of the composition, and a high molecular weight component, said composition having a melt flow rate MFR<SUB>2 </SUB>of 5 g/10 min or more and a density of 915-960 kg/m<SUP>3</SUP>. The composition is extruded on the substrate as such or by adding 10 wt-% or less, calculated from the total weight of the coating, of high pressure PE-LD by blending into the extrusion composition or by coextrusion.
Patent FI-20001010-A0 (FI)
Inventor: HYVAERINEN JAAKKO
IPC: F21V9/00
Filed: 2000-04-28
Abstract: The invention is related to a method and apparatus for modifying the irradiation distribution of a radiation source. In accordance with the method the radiation source (1) is used to direct radiation to an essentially planar target surface (6). In accordance with the invention between the radiation source (1) and the target surface (6), several plates (4), which are essentially transparent to the radiation and have spaces between them, are placed close to the radiation source (1), in order to use the reflection and absorption of the transparent plates (4) to attenuate the radiation to desired areas. <IMAGE>
Patent FI-20022200-A0 (FI)
Inventor: NISSILAE SEPPO
IPC: A61B5/024
Filed: 2002-12-16
Abstract: The invention relates to an arrangement for coding heart rate information, comprising means (600A,600B) for measuring a person's heart beat intervals and means for storing (648) the measured heart beat interval information. The arrangement comprises means (654) for packing the measured heart beat interval information coding the packed heart beat interval information into music, the coding means comprising means (660) for selecting the rhythm of the music on the basis of the measured heart beat intervals. <IMAGE>
Patent FI-20055473-A0 (FI)
Inventor: HAAPAMAEKI TAPANI
IPC: H05K/
Filed: 2005-09-05
Abstract: The invention relates to an arrangement for the cooling of liquid-cooled electric devices, said arrangement being fitted to convey heat produced in the electric devices (3) away from the electric device by means of a liquid flowing through a cooling element of the electric device. The arrangement comprises an instrument cubicle (1) with one or more electric devices (3) placed in it, a cooling apparatus (6), an inlet piping (10) and an outlet piping (11) connecting the electric device and the cooling apparatus for conveying a cooling liquid into the cooling element and out of the cooling element of the electric device (3). The arrangement is characterized in that below the instrument cubicle (1) is arranged a footing element (2) comprising an inlet main pipe (20) and outlet main pipe (21) connected to the cooling apparatus (6), the inlet piping (10) and outlet piping (11) being detachably connected to said main pipes. In addition, the arrangement enables indication of leakage situations occurring in the pipings.
Patent FI-20060610-A0 (FI)
Inventor: SEPPAE HEIKKI
IPC: G06K/
Filed: 2006-06-21
Abstract: The invention relates to an RFID reading device and a method for it. The reading device comprises a transmitter part (1, 30, 31), a receiving part (23, 33), and an antenna (5, 32) or antenna group connected to them. According to the invention, the transmitter part (1, 30, 30) comprises a transformer (10, 34, 35), in which there are at least three coils (11, 12, 13) connecting to the same magnetic field, a first coil (12), a second coil (11), and a third coil (13), of which the antenna or antenna group (5, 32) are fed through the first coil (12), a reference load (17, 18, 19) is connected to the second coil (11) to compensate the effect of the power sent through the first coil (12), and the preamplifier (23, 33) of the receiver is connected to the third coil (13, 36, 37) of the transformer (10, 34, 35).
Patent FI-20075875-A0 (FI)
Inventor: LAURONEN MIKA
IPC: G06K/
Filed: 2007-12-04
Abstract: A device, method and system for forwarding data from a number of RFID devices, wherein data, e.g. ID and/or sensor data, is wirelessly received from the RFID devices (106) via radiofrequency communication and stored by a master device (104) that after receipt of a radio frequency activation signal transmits the data over a WLAN connection towards a remote recipient.
Patent FI-20085582-A0 (FI)
Inventor: KUMPULA TUOMAS
IPC: H04L/
Filed: 2008-06-13
Abstract: The present invention relates to a method for a messaging system, a messaging system, a messenger server and a computer program product. The messaging system comprises a messenger server, a sending client and at least one receiving client, and a data transfer network formed therein between. A message comprising at least a link to web content is created and sent from the sending client to at least one receiving client. The messaging system is configured to determine whether the said at least one receiving client has already received the message, and if not, to deliver an identification referring to the message to said at least one receiving client, and said at least one receiving client is configured to retrieve the message on the basis of the identification from the messenger server, whereby the messaging system is configured to automatically display the content in the message.
Patent IL-113462-A0 (IL)
Title: Substituted pyridylpyrazoles, their preparation and pesticidal compositions containing them
IPC: A01N43/40
Filed: 1995-04-24
Abstract: Substd. pyridylpyrazole cpds. of formula (I) are new. Y = S(O)nCF3; n = 0, 1 or 2.
Patent IL-134966-A0 (IL)
Title: Connector for a corrugated pipe with locking portion
IPC: F16L37/12
Filed: 2000-03-09
Abstract: The locking section has at last one lip (30,32,34,35) lip which engages in a pipe corrugation over an angle of 1800. The individual sections of the lip are closer to a symmetrical axis (54) than the widest distance between facing contours of the lip
Patent IL-139456-A0 (IL)
Title: Compounds for the treatment of female sexual dysfunction
IPC: A61K31/499
Filed: 2000-11-02
Abstract: A pharmaceutical composition (C1) comprising an inhibitor of neutral endopeptidase (NEP) (a1) with carrier, diluent or excipient optionally with additional pharmaceutical agent (preferably NEP, phosphodiesterase (PDE) and/or neuropeptide Y (NPY) inhibitor), is new. Independent claims are included for: (1) performing an assay method for identifying an agent that can be used to treat female sexual dysfunction (FSD) involving determining whether an agent can directly or indirectly potentiate cyclic adenosine-3',5'-monophosphate (cAMP) where a potentiation of cAMP in the presence of the agent is indicative that the agent can be useful in the treatment of FSD where the agent is (a1), identifying at least one agent that can directly or indirectly potentiate cAMP, preparing the identified agents, mixing the identified agent with carrier, diluent or excipient to form (C1), and packaging (C1); (2) an assay process for identifying an agent that can treat FSD involving administering an agent to an animal model, measuring any potentiation of cAMP and/or increase in blood flow in the genitalia of the animal, where the agent is (a1) and the animal model comprises at least one of an anesthetized female animal including device to measure changes in genital blood flow of the animal following stimulation of the pelvic nerve where the agent potentiates cAMP in the sexual genitalia following optionally oral administration; (3) a diagnostic method involving isolating a sample from a female, determining whether the sample contains an entity (e1) to cause FSD, whether the entity has a direct or indirect effect on the level of activity of cAMP in the sexual genitalia of the female and whether the entity can be modulated to achieve a beneficial effect by using (a1); and (4) a diagnostic kit comprising device for detecting (e1) in an isolated female sample, and (a1). ACTIVITY : Endocrine-Gen. MECHANISM OF ACTION : Neutral endopeptidase (NEP) inhibitor; Mediator of female genital vasorelaxation. Test details are described but no results for the specific compounds given.
Patent IL-139575-A0 (IL)
Title: Il-6 antagonist peptides and pharmaceutical compositions containing them
IPC: A61P37/02
Filed: 1999-05-18
Abstract: The present invention relates to IL-6 antagonist peptides, isolatable from a peptide library through the two-hybrids system by their ability to bind to the intracellular domain of gp130 and containing at least 5 amino acids. In particular, such peptides comprise an amino acid sequence, which is selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO:5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, as well as salts, functional derivatives, precursors and analogs thereof. Another object of the present invention is to provide the peptide in substantially purified form, in order to be suitable for use in pharmaceutical compositions as active ingredient in pathologies that require IL-6 activity inhibition.
Patent IL-148337-A0 (IL)
Title: New herbicidal compositions
IPC: A01N41/10
Filed: 2000-09-08
Abstract: The present invention provides a method of reducing phytotoxicity to crops (especially maize) caused by a herbicidal benzoylisoxazole and/or dione derivative of formula (I) or an agriculturally acceptable salt or metal complex thereof; which method comprises applying to the locus of the crop an antidotally effective amount of an antidote compound, optionally with a partner herbicide.
Patent IL-150170-A0 (IL)
Title: Multiple and hybrid graphics display types
IPC: G06F3/14
Filed: 2000-12-11
Abstract: A display interface device and method for an individual personal computer, workstation, or embedded system comprising one or more display interfaces; a video library; and driving any one of a plurality of video displays of a plurality of types connected to the one or more display interfaces from output of the video library. OpenGL is a preferred API. Driving of hybrid displays as well as stroke displays using formats designed for raster displays (such as VAPS) is also provided for. Real-time switching between displays is also provided for.